NutriBand Inc.
Develops abuse-deterrent transdermal patches to make potent drug delivery safer.
NTRB | NDAQ
Overview
Corporate Details
- ISIN(s):
- US67092M2089 (+1 more)
- LEI:
- Country:
- United States of America
- Address:
- 121 S. ORANGE AVE., 32801 ORLANDO
- Website:
- https://nutriband.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Nutriband Inc. is a development-stage pharmaceutical company focused on creating transdermal drug delivery systems integrated with abuse-deterrent technology. The company's core platform is its proprietary AVERSA™ technology, designed to prevent the abuse, misuse, and accidental exposure of potent transdermal medications by incorporating aversive agents into the patch. Nutriband's lead product candidate is AVERSA™ Fentanyl, an abuse-deterrent fentanyl patch aimed at improving patient safety and addressing the opioid crisis. The company's mission is to enhance patient outcomes through innovative drug delivery platforms that combine therapeutic efficacy with safety measures against prescription drug abuse.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all NutriBand Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for NutriBand Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for NutriBand Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
